Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Online Inquery

  • Refresh

Anti-Human CD123 Recombinant Antibody(Talacotuzumab)

Product Information
Catalog Number YR1468
Product Name Anti-Human CD123 Recombinant Antibody(Talacotuzumab)
Molecular Name Talacotuzumab
Alias Anti-CD123 Recombinant Antibody, Research Grade Talacotuzumab
CAS Number 1826831-79-1
Target CD123[Homo sapiens]
Isotype IgG2 Kappa
Clonity Monoclonal
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Buffer PBS, pH7.5
Background Zolbetuximab (development code IMAB362) is an experimental monoclonal antibody against isoform 2 of Claudin-18. It is under investigation for the treatment of gastrointestinal adenocarcinomas and pancreatic tumors. IMAB362 was developed by Ganymed Pharmaceuticals AG. The drug is in phase II clinical trials as of January 2013.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.